StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
PASWPing An Biomedical Co., Ltd.
stockpulse.co.kr
Nasdaq
$4.43▼ 6.93%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $108.8MShares out 24.6M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

6
  • 1d agoAfter-hours26.10.24 06:00
    F-3Offering#●●●#●●●

    Ping An Biomedical Co., Ltd.Bullish

    Ping An Biomedical Co., Ltd. has filed a Form F-3 registration statement to offer and sell up to $300 million in securities, including Class A ordinary shares, debt securities, and warrants. As a controlled company with 91.56% of voting power held by a single shareholder, potential future offerings may lead to dilution for public shareholders.…more

    $4.43-6.93%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 2d agoAfter-hours26.10.23 06:00
    6-KKey event

    Ping An Biomedical Co., Ltd.

    Ping An Biomedical will hold an extraordinary general meeting of shareholders on October 29, 2026, to approve a 40-for-1 share consolidation. The company also seeks authorization for further share consolidations ranging from 10-for-1 to 80-for-1 depending on future stock price performance, which will result in adjustments to share counts and authorized capital.…more

    $4.43-6.93%vs prev close
    View filingShare
  • 3d agoRegular26.10.22 00:00
    6-KKey event

    Ping An Biomedical Co., Ltd.

    Ping An Biomedical will implement a 1-for-40 reverse stock split effective October 23, 2026. Following the split, the number of outstanding shares will be adjusted from 112,867,000 Class A and 12,250,000 Class B shares to approximately 2,821,675 Class A and 306,250 Class B shares. The shares will continue to trade on Nasdaq under the ticker 'PASW' on a split-adjusted basis starting at the market opening on October 23, 2026.…more

    $4.43-6.93%vs prev close
    View filingShare

5 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 1d agoPre-market26.10.23 21:55

    Trading Halt and Resumption Notice

    Trading for the specific stock has resumed following a temporary halt. Investors should review the latest company disclosures to inform their trading decisions.…more

    $4.43-6.93%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 2d agoAfter-hours26.10.23 08:50

    ●●●●●●●● ●●●●● ●●●●●●

    Trading for this security has been temporarily halted pending the release of material news. Investors should exercise caution until further details are disclosed.…more

    $4.43-6.93%vs prev close
    ShareBenzinga
  • 2d agoRegular26.10.23 04:30

    ●●●●●●●● ●●●●● ●●●●●●

    Ping An Biomedical has signed a letter of intent to acquire three tumor cell-related medical technology patents for $2 million to $2.5 million. The company views this as a foundational step for its long-term biotech strategy, though it does not expect material near-term revenue.…more

    $4.43-6.93%vs prev close
    Read sourceShareGlobeNewswire

2 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →